Portal de Periódicos da CAPES

Regulation of Human IgE Synthesis

1996; Wiley; Volume: 796; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1996.tb32567.x

1749-6632

J Y Bonnefoy, Jean‐François Gauchat, Sybille Lecoanet-Henchoz, Pierre Graber, Jean‐Pierre Aubry,

Pluripotent Stem Cells Research

Annals of the New York Academy of SciencesVolume 796, Issue 1 p. 59-71 Regulation of Human IgE Synthesis JEAN-YVES BONNEFOY, JEAN-YVES BONNEFOY Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorJEAN-FRANCOIS GAUCHAT, JEAN-FRANCOIS GAUCHAT Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorSYBILLE LECOANET-HENCHOZ, SYBILLE LECOANET-HENCHOZ Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorPIERRE GRABER AND, PIERRE GRABER AND Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorJEAN-PIERRE AUBRY, JEAN-PIERRE AUBRY Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this author JEAN-YVES BONNEFOY, JEAN-YVES BONNEFOY Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorJEAN-FRANCOIS GAUCHAT, JEAN-FRANCOIS GAUCHAT Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorSYBILLE LECOANET-HENCHOZ, SYBILLE LECOANET-HENCHOZ Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorPIERRE GRABER AND, PIERRE GRABER AND Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this authorJEAN-PIERRE AUBRY, JEAN-PIERRE AUBRY Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A. 14 chemin des Aulx Chase postale 674 1228 Plan-les-Ouates Geneva, SwitzerlandSearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1749-6632.1996.tb32567.xCitations: 14AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Pene, J., F. Rousset, F. Briere, I. ChrÉtien, J. Y. Bonnefoy, H. Spits, T. Yokota, N. Arai, K. Arai and J. Banchereau. 1988. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by intereferons g and a and prostaglandin E2. Proc. Natl. Acad. Sci. U. S. A. 85(18): 6880–6884. 2 Gauchat, J. F., D. A. Lebman, R. L. Coffman, H. Gascan and J. E. DE Vries. 1990. Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production. J. Exp. Med. 172(2): 463–473. 3 Punnonen, J., G. Aversa, B. G. Cocks, A. N. McKenzie, S. Menon, G. Zurawski, R. DE Waal Malefyt and J. E. DE Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U. S. A. 90(8): 3730–3734. 4 Bonnefoy, J. Y. and R. Noelle. 1994. The CD40-CD40L interaction—All things to all immunologists. Res. Immunol. 145(3): 199–240. 5 Kopf, M., G. LE Gros, M. Bachmann, M. C. Lamers, H. Bluethmann and G. Kohler. 1993. Disruption of the murine II-4 gene blocks Tg2 cytokine responses. Nature 362(6417): 245–248. 6 Gascan, H., J. F. Gauchat, G. Aversa, P. Van Vlasselaer and J. E. DE Vries. 1991. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147(1): 8–13. 7 Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman and D. Baltimore. 1994. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267(5203): 1494–1498. 8 Kotanides, H. and N. C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262(5137): 1265–1267. 9 Hou, J., U. Schindler, W. J. Henzel and T. C. Ho. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265(5179): 1701–1706. 10 Johnston, J. A., M. Kawamura, R. A. Kirken, Y. Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar and J. J. O'shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370(6485): 151–153. 11 Miyazaki, T. A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z. J. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn and J. N. Ihle. 1994. Functional activation of Jak-1 and Jak-3 by selective association with IL-2 receptor subunits. Science 266(5187): 1045–1047. 12 Heldin, C. H. 1995. Dimerization of cell surface receptors in signal transduction. Cell 80(2): 213–223. 13 Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80(5): 729–738. 14 D'Ambrosio, D., K. L. Hippen, S. A. Minskoff, I. Mellman, G. Pani, K. A. Siminovitch and J. C. Cambier. 1995. Science 268(5208): 293–297. 15 Hu, M. H., K. O'Rourke, M. S. Boguski and V. M. Dixit. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269(48): 30069–30072. 16 Sato, T., S. Irie and J. C. Reed. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. 1995. FEBS 358(2): 113–118. 17 Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family 1995. Cell 80(3): 389–399. 18 Flores-Romo, L., J. F. Gauchat, P. Graber, J. P. Aubry and J. Y. Bonnefoy. The role of surface molecules in the control of human IgE synthesis. In Molecular Analysis of IgE-Mediated Hypersensitivity and Strategies for Immunological Intervention, A. M. Roberts, Ed. Wiley. London . In press. 19 Yokota, A., H. Kikutani, T. Tanaka, R. Sato, E. L. Basumian, M. Suemura and T. Kishimoto. 1988. Two species of human FcERII (CD23): Tissue-specific and IL-4-specific regulation of gene expression. Cell. 55(4): 611–618. 20 Sarfati, M., E. Rector, K. Wong, M. Rubio-Trujillo, A. H. Sehon and G. Delespesse. 1984. In vitro synthesis of IgE by human B lymphocytes. II. Enhancement of the spontaneous IgE synthesis by IgE-binding factors secreted by RPMI 8866 lymphoblastoid B cells. Immunol. 53(2): 197–214. 21 Sarfati, M. and G. Delespesse. 1988. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. J. Immunol. 141(7): 2195–2199. 22 Thompson, L. F., H. L. Spiegelberg and R. H. Buckley. 1985. IgE Fc receptor positive T and B lymphocytes in patients with the Hyper IgE syndrome. Clin. Exp. Immunol. 59(1): 77–84. 23 Nagai, T., M. Adachi, N. Noro, J. Yodo and H. Uchino. 1985. T and B lymphocytes with Immunoglobulin E Fc receptors (FcER) in patients with nonallergic Hyperimmunoglobulinemia E: Demonstration using a monoclonal antibody against FcER-associated antigen. Clin. Immunol. Immunopathol. 35(3): 261–275. 24 Yanagihara, Y., M. Sarfati, D. Marsh, T. Nutman and G. Delespesse. 1990. Serum levels of IgE-binding factor (soluble CD23) in diseases associated with elevated IgE. Clin. Exp. Allergy 20(4): 395–401. 25 Bengtsson, M., J. Gordon, L. Flores-Romo, J. A. Cairns, B. Smedmyr, G. Oberg, B. Simonsson and T. H. Totterman. 1989. B cell reconstitution after autologous bone marrow transplantation: Increase in serum CD23 precedes IgE and B cell regeneration. Blood 73(8): 2139–2144. 26 DeFrance, T., J. P. Aubry, F. Rousset, B. Vanbervlietet, J. Y. Bonnefoy, N. Arai, Y. Takebe, J. Yokota, F. Lee and K. Arai. 1987. Human recombinant interleukin 4 induces FcER (CD23) on normal B lymphocytes. J. Exp. Med. 165(6): 1459–1467. 27 Bonnefoy, J. Y., J. J. Mermod and J. Shields. 1990. Inhibition of human IL-4 induced IgE synthesis by a subset of anti-CD23/FcERII monoclonal antibodies. Eur. J. Immunol. 20(1): 139–144. 28 Flores-Romo, L., G. D. Johnson, A. A. Ghatderi, D. R. Stanworth, A. Veronesi and J. Gordon. 1990. Functional implication for the topographical association between MHC class II and the low affinity receptor for IgE: Occupancy of CD23 blocks the ability of B cells to present alloantigen to T cells. Eur. J. Immunol. 20(1): 2465–2469. 29 Wang, F., C. D. Gregory, M. Rowe, A. B. Rickinson, D. Wang, M. Birkenbach, H. Kikutani, J. Kishimoto and E. Kieff. 1987. Epstein-Barr virus nuclear antigen-2 specifically induces expression of the B cell activation antigen CD23. Proc. Natl. Acad. Sci. U. S. A. 84(10): 3452–3456. 30 Bjorck, P., C. Elenstrom-Magnusson, A. Rosen, E. Severinson and S. Paulie. 1993. CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur. J. Immunol. 23(6): 1771–1775. 31 Vercelli, D., H. H. Jabara, K. I. Arai and R. S. Geha. 1989. Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC Class II antigens. J. Exp. Med. 169(4): 1295–1307. 32 Aubry, J. P., J. C. Shields, K. U. Jansen and J. Y. Bonnefoy. 1993. A multiparameter flow cytometric method to study surface molecules involved in interactions between subpopulations of cells. J. Immunol. Methods 159(1–2): 161–171. 33 Bevilacqua, M. P., S. Stengelin, M. A. Gimbrone and B. Seed. 1989. Endothelial leukocyte adhesion molecule-1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243(4895): 1160–1165. 34 Bettler, B., R. Maier, D. Ruegg and H. Hofstetter. 1989. Binding site of IgE of the human low affinity receptor (FcERII/CD23) is confined to the domain homologous with animal lectins. Proc. Natl. Acad. Sci. U. S. A. 86(15): 7118–7122. 35 Aubry, J. P., S. Pochon, P. Graber, K. U. Jansen and J. Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358(6386): 505–507. 36 Pochon, S., P. Graber, M. Yaeger, K. Jansen, A. R. Bernard, J. P. Aubry and J. Y. Bonnefoy. 1992. Demonstration of a second ligand for the low affinity receptor for IgE (CD23) using recombinant CD23 reconstituted into fluorescent liposomes. J. Exp. Med. 176(2): 389–397. 37 Gordon, J., L. Flores-Romo, J. Cairns, M. J. Millsum, P. J. Lane, G. D. Johnson and I. C. MacLennan. 1989. CD23: A multi-functional receptor/lymphokine?. Immunol. Today 10: 153–157. 38 Liu, Y. J., J. A. Cairns, M. Holder, S. D. Abbot, K. U. Jansen, J. Y. Bonnefoy, J. Gordon and I. C. MacLennan. 1991. Recombinant 25 kDa CD23 and interleukinl promote the survival of germinal center B cells: Evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 21(5): 1107–1114. 39 Mossalayi, M. D., J. C. Lecron, A. H. Dalloul, M. Sarfati, J. M. Bertho, G. Delespesse and P. DebrÉ. 1990. Soluble CD23 (FcERII) and interleukin-1 synergistically induce early human thymocyte maturation. J. Exp. Med. 171(3): 959–964. 40 Mossalayi, M. D., M. Arock, J. M. Bertho, C. Blanc, A. H. Dalloul, H. Hofstetter, M. Sarfati, G. Delespesse and P. DebrÉ. 1990. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood 75(10): 1924–1927. 41 Capron, A., J. P. Dessaint, M. Capron, M. Joseph, J. C. Ameisen and A. B. Tonnel. 1986. From parasites to allergy: A second receptor for IgE. Immunol. Today 7: 15–18. 42 Kehry, M. R. and L. C. Yamashita. 1989. FcERII (CD23) function on mouse B cells: Role in IgE dependent antigen focusing. Proc. Natl. Acad. Sci. U. S. A. 86(19): 7556–7560. 43 Pirron, U., T. Schlunck, J. C. Prinz and E. P. Rieber. 1990. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low affinity receptor for IgE. Eur. J. Immunol. 20(7): 1547–1551. 44 Grosjean, I., A. Lachaux, C. Bella, J. P. Aubry, J. Y. Bonnefoy and D. Kaiserlan. 1994. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones. Eur. J. Immunol. 24(12): 2982–2986. 45 Texido, G., H. Eibel, G. Le Gros and H. VAN DER Putten. 1994. Transgene CD23 expression on lymphoid cells modulates IgE and IgGI responses. J. Immunol. 153(7): 3028–3042. 46 Fujiwara, H., H. Kikutani, S. Suematsu, T. Naka, K. Yoshida, T. Tanaka, M. Suemura, N. Matsumoto and S. Kojima. 1994. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 91(15): 6835–6839. 47 Morris, S. C., A. Lees, J. M. Holmes, R. D. Jeffries and F. D. Finkelman. 1994. Induction of B cell and T cell tolerance in vivo by anti-CD23 mAb. J. Immunol. 152(8): 3768–3776. 48 Stief, A., G. Texido, G. Sansig, H. Eibel, G. Le Gros and H. VAN DER Putten. 1994. Mice deficient in CD23 reveal its modulatory role in IgE production but no role in T and B cell development. J. Immunol. 152(7): 3378–3390. 49 Yu, P., M. Kosco-Vilbois, M. Richards, G. Kohler and M. C. Lamers. 1994. Negative feedback regulation of IgE synthesis by murine CD23. Nature 369(6483): 753–756. 50 Flores-Romo, L., J. Shields, Y. Humbert, P. Graber, J. P. Aubry, J. F. Gauchat, G. Ayala, B. Allet, M. Chavez, H. Bazin and J.-Y. Bonnefoy 1993. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261(5124): 1038–1041. 51 Bonnefoy, J. Y., O. Guillot, H. Spits, D. Blanchard, K. Ishizaka and J. Banchereau. 1988. The low affinity receptor of IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens. J. Exp. Med. 167(1): 57–72. 52 Mossalayi, D. M., M. Arock, G. Delespesse, H. Hofstetter, B. Bettler, A. H. Dalloul, E. Kilchherr, F. Quaaz, P. Debre and M. Sarfati. 1992. Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. EMBO J. 11(12): 4323–4328. 53 Thyphronitis, G., G. C. Tsokos, C. H. June, A. D. Levine and F. D. Finkelman. 1989. IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon g. Proc. Natl. Acad. Sci. U. S. A. 86(14): 5580–5584. 54 Aubry, J. P., S. Pochon, J. F. Gauchat, A. Nueda-Marin, V. M. Holers, P. Graber, C. Siegfried and J. Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked Oligosaccharides on CD21. J. Immunol. 152(12): 5806–5813. 55 Henchoz-Lecoanet, S., P. Jeannin, J. P. Aubry, P. Graber, C. G. Bradshaw, S. Pochon and J. Y. Bonnefoy. 1996. The Epstein Barr virus-binding site on CD21 is involved in CD23 binding and IL-4 induced IgE and IgG4 production by human B cells. Immunology 88: 35–39. 56 Gagro, A. and S. Rabatic. 1994. Allergen-induced CD23 on CD4+ T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: Evidence and regulation. Eur. J. Immunol. 24(5): 1109–1114. 57 Gagro, A., S. Rabatic, A. Trescec, D. Dekaris and M. Medar-Lasic. 1993. Expression of lymphocytes Fc epsilon RII/CD23 in allergic children undergoing hyposensitization. Int. Arch. Allergy Appl. Immunol. 101(2): 203–208. 58 Lecoanet-Henchoz, S., J. F. Gauchat, J. P. Aubry, P. Graber, P. Life, N. Paul-EugÈne, B. Ferrua, A. L. Corbi, B. Dugas, C. Plater-Zyberk and J. Y. Bonnefoy. 1995. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11 b/CD18 and CD11c/CD18. Immunity 3: 119–125. 59 Takigawa, M., T. Tamamori, D. Horiguchi, T. Sakamoto, M. Yamada, A. Yoshioka, K. Toda, S. Imamura and J. Yodoi. 1991. FcER II/CD23 positive lymphocytes in atopic dermatitis. I. The proportion of FcERII + lymphocytes correlates with the extent of skin lesion. Clin. Exp. Immunol. 84(2): 275–282. 60 Armitage, R. J., L. K. Goff and P. C. L. Beverley. 1989. Expression and functional role of CD23 on T cells. Eur. J. Immunol. 19(1): 31–35. 61 Prinz, J. C., X. Baur, G. Mazur and E. P. Rieber. 1990. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon g. Eur. J. Immunol. 20(6): 1259–1264. 62 Yamaoka, K. A., S. Tsukidate, M. Higaki, N. Mryasaka and K. Fujita. 1991. Induction of FcERII/CD23 on human T cells by excretory and secretory antigen of Dirofilaria immitis. Int. Arch. Allergy Appl. Immunol. 95(1): 92–93. 63 Bonnefoy, J. Y., S. Henchoz, D. Hardie, M. J. Holder and J. Gordon. 1993. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23(4): 969–972. 64 Maeda, K., G. F. Burton, D. A. Padgett, D. H. Conrad, T. F. Huff, A. Masuda and A. K. Szakal. 1992. Murine follicular dendritic cells and low affinity Fc receptors for IgE (FcERII). J. Immunol. 148(8): 2340–2347. 65 Mitani, S., K. Takagi, T. Oka and S. Mori. 1988. Increased Immunoglobulin E Fc receptor bearing cells in germinal centers of hyperimmunoglobulinemia E patients. Int. Arch. Allergy Appl. Immunol. 87(1): 63–69. 66 Okumura, K. and T. Tada. 1971. Regulation of homocytotropic antibody formation in the rat. Ill. Effect of thymectomy and splenectomy. J. Immunol. 106: 1019–1025. 67 Jabara, H. H., S. M. Fu, R. S. Geha and D. Vercelli. 1990. CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172(6): 1861–1864. 68 Stamenkovic, I., E. A. Clark and B. Seed. 1989. A B lymphocyte activation molecule related to nerve growth factor receptor and induced by cytokines. EMBO J. 8(5): 1403–1410. 69 Gordon, J., M. J. Millsum, G. R. Guy and J. A. Ledbetter. 1988. Resting B lymphocytes can be triggered directly through the CDW40 (Bp50) antigen. J. Immunol. 140(5): 1425–1430. 70 Barrett, T. B., G. Shu and E. A. Clark. CD40 signalling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146(6): 1722–1729. 71 Flores-Romo, L., D. Estoppey and K. B. Bacon. 1993. Anti-CD40 antibody stimulates the VLA-4-dependent adhesion of normal and LFA-1-deficient B cells to endothelium. Immunology. In press. 72 Liu, Y. J., D. E. Joshua, G. T. Williams, C. A. Smith, G. Gordon and I. C. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centers. Nature 342(6252): 929–931. 73 Banchereau, J., P. DE Paoli, A. Valle, E. Garcia and F. Rousset. 1991. Long-term growth of human B cell lines dependent on interleukin 4 and antibody to CD40. Science 251(4989): 70–72. 74 Shapira, S. K., D. Vercelli, H. H. Jabara, S. M. Fu and R. S. Geha. 1992. Molecular analysis of the induction of immunoglobulin IgE synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175(1): 289–292. 75 Gauchat, J. F., G. Aversa, H. Gascan and J. E. DE Vries. 1992. Modulation of IL-4 induced germline e RNA synthesis in human B cells by tumor necrosis factor a, anti-CD40 monoclonal antibodies or transforming growth factor b correlates with levels of IgE production. Int. Immunol. 4(3): 397–406. 76 Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith and C. R. Maliszewski. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357(6373): 80–82. 77 Hollenbaugh, D., L. S. Grosmaire, C. D. Kullas, N. J. Chalupny, S. Braesch-Andersen, R. J. Noelle, I. Stamenkovic, J. A. Ledbetter and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 12(11): 4313–4321. 78 Graf, D., U. Korthauer, H. W. Mages, G. Senger and R. A. Kroczek. 1992. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22(12): 3191–3194. 79 Spriggs, M. K., R. J. Armitage, L. Strockbine, K. N. Clifford, B. M. Macduff, T. A. Sato, C. R. Maliszewski and W. C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176(6): 1543–1550. 80 Gauchat, J. F., J. P. Aubry, G. Mazzei, P. Life, T. Jomotte, G. Elson and J. Y. Bonnefoy. 1993. Human CD40-ligand: Molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett. 315(3): 259–266. 81 Disanto, J. P., J. Y. Bonnefoy, J. F. Gauchat, A. Fischer and G. DE Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361(6412): 541–543. 82 Korthauer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky and R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361(6412): 539–541. 83 Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grosmaire, R. Stenkamp and M. Naubauer. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72(2): 291–300. 84 Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche and D. K. Simoneaux. 1993. CD40 ligand defects responsible for X-linked hyper-IgM syndrome. Science 259(5097): 990–993. 85 Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R. S. Rosen, T. Chatila, S. M. Fu, I. Stamenkovic and R. S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. U. S. A. 90(6): 2170–2173. 86 Gauchat, J. F., S. Henchoz, G. Mazzei, J. P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Romo, J. Thompson, K. Kishi, J. Butterfield, C. Dahinden and J. Y. Bonnefoy. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365(6444): 340–343. 87 Gauchat, J. F., S. Henchoz, D. Fattah, G. Mazzei, J. P. Aubry, T. Jomotte, L. Dash, K. Page, R. Solari, D. Aldebert, M. Capron, C. Dahinden and J. Y. Bonnefoy. 1995. CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 25(3): 863–865. 88 Piccinni, M. P., D. Macchia, P. Parronchi, M. G. Giudizi, D. Bani, R. Alterni, A. Grossi, M. Ricci, E. Maggi and S. Romagnani. 1991. Human bone marrow non-B, non-T cells produce interleukin 4 in responses to cross-linkage of Fce and Fcg receptors. Proc. Natl. Acad. Sci. U. S. A. 88(19): 8656–8660. 89 Brunner, T., C. H. Heusser and C. A. Dahinden. 1993. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177(3): 605–611. 90 Brown, M. A., J. H. Pierce, C. J. Watson, J. Falco, J. N. Ihle and W. E. Paul. 1987. B Cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50(5): 809–818. 91 Lederman, F., C. Heusser, C. Schleinger and G. Le Gros. 1992. Interleukin 3-treated non-B, non-T cells switch activated B cells to IgG 1 /IgE synthesis. Eur. J. Immunol. 22(11): 2783–2787. Citing Literature Volume796, Issue1Cytokines and Adhesion Molecules in Lung InflammationOctober 1996Pages 59-71 ReferencesRelatedInformation